Mengxue Wang
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Tailored Porous Bimetallic Nanozyme Platform for Full-Cycle Therapeutics of Intestinal Ischemia/Reperfusion.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 21, 2025
Loss of RPN1 promotes antitumor immunity via PD-L1 checkpoint blockade in triple-negative breast cancer - experimental studies.
Journal: International journal of surgery (London, England)
Published: April 22, 2024
EDNRA regulates the tumour immune environment and predicts the efficacy and prognosis of cancer immunotherapy.
Journal: Journal of cellular and molecular medicine
Published: March 20, 2024
IGJ suppresses breast cancer growth and metastasis by inhibiting EMT via the NF‑κB signaling pathway.
Journal: International journal of oncology
Published: April 04, 2023
AMPD1 Is Associated With the Immune Response and Serves as a Prognostic Marker in HER2-Positive Breast Cancer.
Journal: Frontiers in oncology
Published: August 24, 2021
Prevalence of Thyroid Nodules in China: A Health Examination Cohort-Based Study.
Journal: Frontiers in endocrinology
Published: March 04, 2021
Efficacy and Safety of Adding Immune Checkpoint Inhibitors to Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials.
Journal: Frontiers in oncology
Published: January 29, 2021
Immunoglobulin superfamily member 10 is a novel prognostic biomarker for breast cancer.
Journal: PeerJ
Published: February 24, 2020
Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.
Journal: JAMA network open
Published: January 04, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026